Patients Invited into  ‘Gentle IVF’ Clinical Study

Midland Fertility  is seeking 60 IVF patients to participate in a comparative trial of two tried and tested fertility drugs.

The trial started in March 2014 and, so far, Midland Fertility is delighted to report a clinical pregnancy rate of over 60%.

Midland Fertility is the only UK clinic chosen to participate in the new European-wide study.  This follows the success of a previous trial at the Tamworth-based unit, which achieved very positive live birth rates, well above the national average.

The drugs trial is being managed by nurse manager Mandy Godwin and clinical resaearch fellow Dr Nirmal Felix
The drugs trial is being managed by clinical research fellow Dr Nirmal Felix pictured with nurse manager Mandy Godwin

To participate, the woman patient should be 38 years old or younger, within a normal weight range, not suffer from polycystic ovaries (PCOS), and have had no more than two earlier IVF egg collections.  Tests at Midland Fertility will also establish that she has a normal ovarian reserve.  The couples should need either IVF or ICSI treatment, even with donor sperm, but not with surgically retrieved sperm.

“In previous similar multi-centre drug trials, Midland Fertility achieved the highest pregnancy rates,” said nurse manager Mandy Godwin.  “So we are delighted to offer patients the chance to benefit from a similar opportunity, which carries no more risks than any standard IVF or ICSI cycle.”

For information about being a part of the trial at Midland Fertility, email the nurses quoting ‘drug trial’ in the subject box, or call 01827 311170.


pr132.IBSA trial1.mar14.jlaa

Issued: 10 March 2014 (updated 30 October 2014)